JCB logo
amgmicro.com
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JCB
Citing Articles
Right arrow Citing Articles via CrossRef
[HELP with High Resolution Image Viewing] [To Article]

[View Larger Version of this Image]

Supplemental Figure 1. Microinjection of the dominant-negative N17Cdc42 recombinant protein does not block HA/CD44-induced lamellipodial formation. EGFP-ß-actin-expressing cell was microinjected into N17Cdc42 recombinant protein and, subsequently, treated with HA. Note the formation of new lamellipodia in response to HA.

see also Video 8 (9.8 MB)

[To Article]



This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JCB
Citing Articles
Right arrow Citing Articles via CrossRef

  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents